Search

everythinglearnresearchcommunity

for

Search:↓

The committee decided not to approve the drug due to low effectiveness and high risks.

Herbomineral drugs effectively manage chemotherapy-induced diarrhea in oral cavity cancer patients.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

A rare nail bed cancer was successfully treated with no recurrence after 4 years.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

The technique of using a skin and hair graft from behind the ear successfully reconstructed a large eyebrow defect with good cosmetic results.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Trichilemmal carcinoma shares genetic changes with other skin cancers, suggesting similar causes and potential treatments.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Rare skin cancer can mimic hair loss conditions, so thorough diagnosis is crucial.

Trichilemmal carcinoma is a rare skin cancer that requires careful diagnosis and follow-up.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

SOX4 is crucial for the development of melanoma.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Dr. Dzubow concluded that careful attention to detail is crucial for the success of Mohs surgery in treating skin cancer.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

The meeting discussed various skin conditions, treatments, and unusual cases, highlighting the effectiveness of tetracycline in treating rosacea.

Patients with multiple superficial venous thrombosis are at greater risk for serious complications like cancer and recurrent blood clots.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.